About RheoMed
We are physician founded and led. Our culture promotes collaborative learning amongst our group. Physician engagement helps drives patient engagement which drive outcomes and lower costs.
Board of Directors
Tarun Marwaha, M.D.
Chairman of the Board
Eric Wechsler, MD
CMO & Board Member
Bruce Greenfield, M.D.
Board Member
Executive Team
Eric Wechsler, MD
CMO
Dr. Wechsler believes very strongly that kidney disease and the associated conditions of heart disease and diabetes can be prevented or slowed with early detection and treatment. His general philosophy in medicine is to educate his patients so they will be empowered to aid the doctor in treating their disease.
Abra Siegel, MBA
CDO
Abra Siegel has over 25 years of experience in healthcare and has held various senior positions. She has lead the development of multiple IPA’s and MSO’s, as well as medical group acquisitions for Health Dimensions (now HCA), Tenet Health System and Sutter Health System. She also has lead the negotiations and payer strategy for both institutional and professional contracting with expertise in VBC arrangements in multiple states. While at Stanford Health Care, she lead the strategic development of various service lines in partnership with the Chairs and Chiefs of the Stanford SOM.
Management Team
Seleste Childers
Director of Operations
Seleste Childers brings in over 7 years of experience fueled by a background in Revenue Cycle Management and attainment of her Certified Professional Coder License. She was able to hone her skills previously as a Client Manager where she was entrusted with the responsibility of overseeing multiple practices and took pride in ensuring that their financials were not just managed but maximized. Here at RheoMed Seleste is responsible for many of the operational intricacies. Her role demands a strategic mindset, an unwavering attention to detail, and a profound commitment to professionalism.
Brain Brady, MD
Board Advisor
Dr. Brady is a board-certified, fellowship-trained nephrologist and Clinical Associate Professor at Stanford University School of Medicine. He specializes in the treatment of chronic kidney disease (CKD), end-stage kidney disease(ESKD), resistant hypertension, and glomerular disorders. His value-based care research has been funded by the NIH and health systems to study care models focused on improving clinical outcomes and reducing costs for patients with CKD and ESKD.
Dr. Brady has published in leading journals such as JAMA Internal Medicine and the Journal of the American Society of Nephrology, has presented nationally and internationally, and served on a national policymaking committees to help improve the system of care for patients with kidney disease. Dr. Brady brings extensive academic leadership and accountable care expertise, further
bolstering RheoMed’s credibility and excellence with payers, partners, and providers across the network and beyond.
Contact us today.
Company Information:
625 The City Drive, Suite 310
Orange, CA 92868
866-433-9943